Michael E. Troka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael E. Troka has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- James Christopher Gates
Department of Oral and Maxillofacial Surgery University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications - Adolfo Rojas
Unidad de Genómica Avanzada - UGA, Advanced Center for Chronic Diseases - ACCDiS, Departamento de Bioquímicas y Biología Molecular, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile
1 shared publication Alessandro Villa
1 shared publication- Dana T. Graves
Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, USA
1 shared publication - Erick Armingol
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
1 shared publication - Hamideh Afzali
Department of Periodontics, School of Dental Medicine University of Pennsylvania Philadelphia Pennsylvania USA
1 shared publication
Latest Publications
- 8 September 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (9) , 1018-1028
Multimodal risk assessment for oral potentially malignant disorders
- 8 September 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (9) , 1018-1028
Multimodal risk assessment for oral potentially malignant disorders
- 1 September 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (9)
Predicting Oral Cancer From Precursor Lesions: Assessing Current Methods and Future Directions
PURPOSE: Oral potentially malignant disorders (OPMDs) pose a significant clinical challenge due to their potential to develop into oral squamous cell carcinoma, a prevalence of 4%-5% of the US population, and malignant transformation rates that approach 10%. Current methods to assess risk of OPMD progression to oral cancer are fraught with limitations and incompletely predict risk. METHODS: We review existing diagnostic and prognostic tools for OPMDs, examining their validation evidence, performance characteristics, and clinical utility. RESULTS: Although some tools provide rule-in or rule-out capabilities, each tool interrogates a single biological layer, and none provides comparable positive predictive value and negative predictive value in a single tool. CONCLUSION: A framework integrating multiomic data across multiple different biologic processes and time points inclusive of benign mimics is needed to better identify which lesions are true OPMDs, and which warrant escalation and intervention versus surveillance or de-escalation.
- 1 September 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (9)
Predicting Oral Cancer From Precursor Lesions: Assessing Current Methods and Future Directions
PURPOSE: Oral potentially malignant disorders (OPMDs) pose a significant clinical challenge due to their potential to develop into oral squamous cell carcinoma, a prevalence of 4%-5% of the US population, and malignant transformation rates that approach 10%. Current methods to assess risk of OPMD progression to oral cancer are fraught with limitations and incompletely predict risk. METHODS: We review existing diagnostic and prognostic tools for OPMDs, examining their validation evidence, performance characteristics, and clinical utility. RESULTS: Although some tools provide rule-in or rule-out capabilities, each tool interrogates a single biological layer, and none provides comparable positive predictive value and negative predictive value in a single tool. CONCLUSION: A framework integrating multiomic data across multiple different biologic processes and time points inclusive of benign mimics is needed to better identify which lesions are true OPMDs, and which warrant escalation and intervention versus surveillance or de-escalation.
- Open Access
- 4 November 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70217
Single Cell Sequencing Identifies Distinct Cellular Alterations in Impaired Aged and Diabetic Wounds
Impaired wound healing in aged and diabetic wounds involves complex cellular dysregulation that hinders tissue repair. Using single‐cell RNA sequencing (scRNA‐seq) and validation techniques, we investigated impaired wound healing to identify whether there were significant changes linked to each condition. Comparative mucosal wound analysis revealed distinct differences between diabetic and normoglycemic (NG)‐aged mice, which had an impact on connective tissue formation and epithelial closure. Wounds in NG‐aged mice exhibited prolonged granulation tissue and upregulation of genes linked to chemotaxis, cell migration, neutrophil degranulation, and antimicrobial defense pathways compared to the diabetic wounds. In comparison to healing in young animals, wounds in NG‐aged mice had a shift in fibroblast subtypes with fewer matrix‐producing myofibroblasts and increased inflammatory fibroblasts. Furthermore, wounds in NG‐aged mice versus wounds in diabetic mice had an upregulation of lytic enzymes, with striking differences in cathepsin‐expressing fibroblasts. Since diabetic wounds healed more slowly than wounds in NG‐aged mice, the results suggest that the upregulation of lytic enzymes that characterized diabetic wounds is particularly damaging to healing. In addition to the transcriptional differences, pseudotime analysis revealed that fibroblasts in wounds from diabetic mice progressed towards a protease‐enriched state, while those in aged mice shifted towards an inflammatory phenotype. This is the first study to directly compare aged and diabetic healing at the single‐cell level and provides distinct molecular mechanisms that may allow more precise therapeutic targets to improve healing in aged and diabetic wounds.
- 4 November 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70217
Open AccessSingle Cell Sequencing Identifies Distinct Cellular Alterations in Impaired Aged and Diabetic Wounds
Impaired wound healing in aged and diabetic wounds involves complex cellular dysregulation that hinders tissue repair. Using single‐cell RNA sequencing (scRNA‐seq) and validation techniques, we investigated impaired wound healing to identify whether there were significant changes linked to each condition. Comparative mucosal wound analysis revealed distinct differences between diabetic and normoglycemic (NG)‐aged mice, which had an impact on connective tissue formation and epithelial closure. Wounds in NG‐aged mice exhibited prolonged granulation tissue and upregulation of genes linked to chemotaxis, cell migration, neutrophil degranulation, and antimicrobial defense pathways compared to the diabetic wounds. In comparison to healing in young animals, wounds in NG‐aged mice had a shift in fibroblast subtypes with fewer matrix‐producing myofibroblasts and increased inflammatory fibroblasts. Furthermore, wounds in NG‐aged mice versus wounds in diabetic mice had an upregulation of lytic enzymes, with striking differences in cathepsin‐expressing fibroblasts. Since diabetic wounds healed more slowly than wounds in NG‐aged mice, the results suggest that the upregulation of lytic enzymes that characterized diabetic wounds is particularly damaging to healing. In addition to the transcriptional differences, pseudotime analysis revealed that fibroblasts in wounds from diabetic mice progressed towards a protease‐enriched state, while those in aged mice shifted towards an inflammatory phenotype. This is the first study to directly compare aged and diabetic healing at the single‐cell level and provides distinct molecular mechanisms that may allow more precise therapeutic targets to improve healing in aged and diabetic wounds.